CC Stock Forecast 2025-2026
Distance to CC Price Targets
CC Price Momentum
10 Quality Stocks Worth Considering Now
Researching Chemours (CC) after the drop? Our ex-Goldman Sachs analyst reveals if it made our list of 10 oversold quality stocks with strong growth potential.
Get our FREE market selloff report + exclusive analysis on CC and similar high-potential opportunities.
Latest CC Stock Price Targets & Analyst Predictions
Based on our analysis of 16 Wall Street analysts, CC has a neutral consensus with a median price target of $21.50 (ranging from $18.00 to $27.00). The overall analyst rating is Buy (7.2/10). Currently trading at $13.83, the median forecast implies a 55.5% upside. This outlook is supported by 4 Buy, 6 Hold, and 0 Sell ratings.
The most optimistic forecast comes from John McNulty at BMO Capital, projecting a 95.2% upside. Conversely, the most conservative target is provided by Jeffrey Zekauskas at JP Morgan, suggesting a 30.2% upside.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
CC Analyst Ratings
CC Price Target Range
Latest CC Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for CC.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| Feb 24, 2025 | Barclays | Michael Leithead | Equal-Weight | Maintains | $19.00 |
| Feb 19, 2025 | BMO Capital | John McNulty | Outperform | Maintains | $27.00 |
| Jan 28, 2025 | Truist Securities | Peter Osterland | Buy | Initiates | $27.00 |
| Jan 13, 2025 | Morgan Stanley | Vincent Andrews | Equal-Weight | Maintains | $22.00 |
| Jan 7, 2025 | Goldman Sachs | Duffy Fischer | Neutral | Maintains | $21.00 |
| Jan 7, 2025 | Mizuho | John Roberts | Neutral | Maintains | $21.00 |
| Dec 12, 2024 | RBC Capital | Arun Viswanathan | Outperform | Reiterates | $25.00 |
| Nov 6, 2024 | RBC Capital | Arun Viswanathan | Outperform | Maintains | $25.00 |
| Nov 5, 2024 | Barclays | Michael Leithead | Equal-Weight | Maintains | $23.00 |
| Nov 5, 2024 | Morgan Stanley | Vincent Andrews | Equal-Weight | Maintains | $25.00 |
| Oct 11, 2024 | RBC Capital | Arun Viswanathan | Outperform | Maintains | $28.00 |
| Oct 7, 2024 | BMO Capital | John McNulty | Outperform | Maintains | $32.00 |
| Sep 25, 2024 | Barclays | Michael Leithead | Equal-Weight | Maintains | $21.00 |
| Sep 3, 2024 | Goldman Sachs | Duffy Fischer | Neutral | Maintains | $23.00 |
| Aug 6, 2024 | JP Morgan | Jeffrey Zekauskas | Neutral | Maintains | $18.00 |
| Aug 6, 2024 | BMO Capital | John McNulty | Outperform | Maintains | $30.00 |
| Aug 6, 2024 | UBS | Joshua Spector | Buy | Maintains | $28.00 |
| Aug 6, 2024 | Barclays | Michael Leithead | Equal-Weight | Maintains | $22.00 |
| Jul 9, 2024 | UBS | Joshua Spector | Buy | Upgrade | $30.00 |
| Jun 7, 2024 | Mizuho | John Roberts | Neutral | Initiates | $25.00 |
Chemours Co. (CC) Competitors
The following stocks are similar to Chemours based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
Chemours Co. (CC) Financial Data
Chemours Co. has a market capitalization of $2.07B with a P/E ratio of 24.3x. The company generates $5.78B in trailing twelve-month revenue with a 1.5% profit margin.
Revenue growth is -1.3% quarter-over-quarter, while maintaining an operating margin of +3.4% and return on equity of +12.8%.
Valuation Metrics
Growth & Margins
Financial Health
Get All 10 Quality Stocks For This Market Selloff
Still researching investments after the market drop? Our ex-Goldman Sachs analyst has already identified the 10 highest-quality oversold stocks with strong fundamentals and upside potential.
Why spend hours researching when we've already done the work? Get instant access to our complete market selloff analysis.
Chemours Co. (CC) Business Model
About Chemours Co.
Global provider of performance chemicals.
Chemours Co. generates revenue by manufacturing and selling a diverse range of chemical products, including titanium technologies, fluoroproducts, and chemical solutions. These products cater to multiple industries such as automotive, electronics, and energy, enhancing the performance and quality of finished goods.
The company is headquartered in Wilmington, Delaware, and focuses on innovation and sustainability, adapting to industry demands while adhering to environmental standards. Its extensive global presence positions it as a significant player in the chemicals sector.
Company Information
Sector
Basic Materials
Industry
Specialty Chemicals
Employees
6,000
CEO
Ms. Denise M. Dignam
Country
United States
IPO Year
2015
Website
www.chemours.comChemours Co. (CC) Latest News & Analysis
Chemours (CC) reported earnings 30 days ago; investors may want to monitor upcoming developments and stock performance trends.
Chemours' recent earnings report may influence its stock performance, impacting investor sentiment and future price movements based on financial health and market expectations.
CC is partnering with industry leaders to conduct trials of its Opteon 2P50 product, aiming to address cooling challenges in data centers.
CC's partnership and product trials signal innovation in data center efficiency, potentially reducing operational costs and enhancing competitiveness, which can boost investor confidence and stock performance.
CC and Energy Fuels are collaborating to enhance the supply chains for rare earth and critical minerals in the U.S. domestic market.
The partnership enhances U.S. rare earth and critical mineral supply, potentially boosting domestic production and reducing reliance on imports, impacting market dynamics and stock valuations.
Chemours and Energy Fuels are forming a strategic alliance to establish a domestic supply chain for critical minerals in the U.S.
The alliance between Chemours and Energy Fuels could enhance domestic supply chains for critical minerals, impacting market dynamics, regulatory support, and investment opportunities in the sector.
Energy Fuels Inc. and The Chemours Company are forming a strategic alliance to boost U.S. rare earth and critical mineral supply chains, leveraging their operational synergies.
The alliance between Energy Fuels Inc. and Chemours enhances U.S. rare earth supply chains, potentially boosting market position and profitability amid rising demand for critical minerals.
Chemours Joins Forces with NTT DATA and Hibiya Engineering, Ltd. For Full-Scale Opteon™ 2P50 Product Trial
13 days agoChemours partners with NTT DATA and Hibiya Engineering for a full-scale trial of its Opteon™ 2P50 product, signaling advancements in their product development efforts.
Chemours' collaboration on the Opteon™ 2P50 trial may enhance product innovation and market position, potentially impacting future revenues and investor sentiment.
Frequently Asked Questions About CC Stock
What is Chemours Co.'s (CC) stock forecast for 2025?
Based on our analysis of 16 Wall Street analysts, Chemours Co. (CC) has a median price target of $21.50. The highest price target is $27.00 and the lowest is $18.00.
Is CC stock a good investment in 2025?
According to current analyst ratings, CC has 4 Buy ratings, 6 Hold ratings, and 0 Sell ratings. The stock is currently trading at $13.83. Always conduct your own research and consider your investment goals before making investment decisions.
What is the long-term price prediction for CC stock?
Wall Street analysts predict CC stock could reach $21.50 in the next 12 months. This represents a 55.5% increase from the current price of $13.83. Please note that this is a projection by Wall Street analysts and not a guarantee.
What is Chemours Co.'s business model?
Chemours Co. generates revenue by manufacturing and selling a diverse range of chemical products, including titanium technologies, fluoroproducts, and chemical solutions. These products cater to multiple industries such as automotive, electronics, and energy, enhancing the performance and quality of finished goods.
What is the highest forecasted price for CC Chemours Co.?
The highest price target for CC is $27.00 from John McNulty at BMO Capital, which represents a 95.2% increase from the current price of $13.83.
What is the lowest forecasted price for CC Chemours Co.?
The lowest price target for CC is $18.00 from Jeffrey Zekauskas at JP Morgan, which represents a 30.2% increase from the current price of $13.83.
What is the overall CC consensus from analysts for Chemours Co.?
The overall analyst consensus for CC is neutral. Out of 16 Wall Street analysts, 4 rate it as Buy, 6 as Hold, and 0 as Sell, with a median price target of $21.50.
How accurate are CC stock price projections?
Stock price projections, including those for Chemours Co., are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
Important Disclaimer
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.
